Does niacin help move fat from liver to fat tissue?
Treatments studied
Part of Digestive system clinical trials.
This study tests if niacin (a B vitamin) can help the body store fat safely in fat tissue instead of letting it build up in the liver. It may be an option for people with fatty liver linked to belly fat, without serious liver damage or other health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 80 years old.
- You must have fatty liver disease (MASLD) with extra belly fat.
- You cannot have advanced liver scarring or severe liver problems.
- You must not have heart disease, kidney disease, or an active cancer (other than skin cancer).
- You must not have an egg allergy or be allergic to niacin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding navy beans to your regular diet can reduce liver fat and improve liver health in people with a type of fatty liver disease called MASLD. You'll eat beans daily for several months and attend regular checkups, including MRI scans and blood tests.
This study tests whether nicotinamide (a form of vitamin B3) can help reduce liver scarring in people with nonalcoholic fatty liver disease. You may qualify if you have moderate to severe liver scarring and are between 18 and 85 years old.
This study looks at how niacin (a B vitamin) affects fat metabolism in people who are overweight or have extra belly fat. It may help researchers understand how to better manage weight-related health problems.
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
This study tests whether a supplement called betaine can reduce liver fat and damage in people with a type of fatty liver disease that includes inflammation. Half of the participants will receive betaine, and half will receive a placebo (a pill with no active ingredient).
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
Hear when a new Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.